|
Forest Laboratories, Inc - SWOT AnalysisPublished by: Datamonitor Published: Jun. 4, 2008 - 26 Pages Table of Contents
AbstractDatamonitor's Forest Laboratories, Inc - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.Forest Laboratories (Forest) is engaged in developing, manufacturing and selling both branded and generic forms of ethical drug products and over the counter products. The company primarily operates in the US. The company is headquartered in New York City, New York and employs more than 5,100 people. The company recorded revenues of $3,441.7 million during the fiscal year ended March 2007, an increase of 16.2% over 2006. The increase was mainly due to the strong sales of Lexapro and Namenda. The operating profit of the company was $708.8 million during fiscal year 2007, a decrease of 18.4% over 2006. The net profit was $454.1 million in fiscal year 2007, a decrease of 35.9% over 2006. Scope of the Report
Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||